
Valeant says it is likely to restate its financial results for the last two years, in the wake of the …

Former pharma chief exec Martin Shkreli has been issued with a subpoena by the US House of representatives, compelling him …

This could prove a make-or-break year for Valeant.The specialist drug company begins 2016 with a reputation damaged by allegations of …

